scholarly journals Cinobufagin, a bufadienolide, activates ROS-mediated pathways to trigger human lung cancer cell apoptosis in vivo

RSC Advances ◽  
2017 ◽  
Vol 7 (40) ◽  
pp. 25175-25181 ◽  
Author(s):  
Panli Peng ◽  
Junhong Lv ◽  
Changqing Cai ◽  
Shaohuan Lin ◽  
Enqing Zhuo ◽  
...  

Lung cancer, as the most common malignancy worldwide, is one of the most threatening diseases for human beings.

2013 ◽  
Vol 54 (11) ◽  
pp. 3116-3129 ◽  
Author(s):  
Robert Ramer ◽  
Udo Walther ◽  
Philipp Borchert ◽  
Stefan Laufer ◽  
Michael Linnebacher ◽  
...  

2013 ◽  
Vol 2 (1) ◽  
pp. 16 ◽  
Author(s):  
Ping Wang ◽  
Zhenhe Suo ◽  
Mengyu Wang ◽  
Hanne K Høifødt ◽  
Øystein Fodstad ◽  
...  

2009 ◽  
Vol 15 (4) ◽  
pp. 623-630 ◽  
Author(s):  
Tao Ren ◽  
Lin Xu ◽  
Shuxian Jiao ◽  
Yanying Wang ◽  
Yingyun Cai ◽  
...  

Oncotarget ◽  
2016 ◽  
Vol 7 (9) ◽  
pp. 10345-10362 ◽  
Author(s):  
Udo Walther ◽  
Kristin Emmrich ◽  
Robert Ramer ◽  
Nadine Mittag ◽  
Burkhard Hinz

2019 ◽  
Vol 28 (12) ◽  
pp. 1664-1673 ◽  
Author(s):  
Yong Li ◽  
Yanxia Yang ◽  
Xiaoping Liu ◽  
Yiwen Long ◽  
Yonghua Zheng

Protein arginine methyltransferase 5 (PRMT5) is implicated in various types of human cancer and tumor development, especially in lung cancer. Nevertheless, it is still unclear whether suppression of PRMT5 could promote lung cancer cell apoptosis and chemosensitivity induced by resveratrol, and the underlying molecular mechanism remains completely unknown. Here, we showed that PRMT5 was overexpressed in human lung cancer tissues and different types of lung cancer cell lines. Moreover, we constructed PRMT5 stable knockdown cell lines (A549 and ASCT-a-1) and investigated the roles of PRMT5 and the related signaling pathway in lung cancer cell apoptosis induced by resveratrol. Our results indicated that inhibition or down-regulation of PRMT5 by GSK591, a PRMT5-specific inhibitor, or shRNAs markedly enhanced cell apoptosis and chemosensitivity stimulated by resveratrol. Further investigation showed that inhibition or down-regulation of PRMT5 further reduced Akt/GSK3β phosphorylation and the downstream targets cyclin D1 and E1 expression upon resveratrol treatment. Our findings suggest that PRMT5 is a pivotal mediator for human lung cancer cell death induced by resveratrol, which also reveals that PRMT5 may serve as a new therapeutic target for the treatment of human lung cancer.


Sign in / Sign up

Export Citation Format

Share Document